Clinical Trial Update: Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of an anti-allergy drug used with a contact lens for allergic conjunctivitis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Unspecified anti-allergy drug with contact lens

Snippet

Sponsor: Vistakon Pharmaceuticals | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED